Early Fast-Track Versus Standard Care for Persons With HIV Initiating TLD
Condition: HIV-1-infection Interventions: Other: Early fast-track care; Other: Standard (deferred fast-track) care Sponsors: Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic; Brigham and Women's Hospital; Weill Medical College of Cornell University; Florida International University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 17, 2020 Category: Research Source Type: clinical trials
Continuation of Protease-Inhibitor Based Second-Line Therapy vs. Switch to B/F/TAF in Virologically Suppressed Adults
Conditions: HIV-1-infection; Antiretroviral Therapy Interventions: Drug: Continuation of boosted PI; Drug: B/F/TAF Sponsors: Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic; Brigham and Women's Hospital; Harvard Medical School; Analysis Group, Inc.; Weill Medical College of Cornell University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 17, 2020 Category: Research Source Type: clinical trials
Early Fast-Track Versus Standard Care for Persons With HIV Initiating TLD
Condition: HIV-1-infection Interventions: Other: Early fast-track care; Other: Standard (deferred fast-track) care Sponsors: Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic; Brigham and Women's Hospital; Weill Medical College of Cornell University; Florida International University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 17, 2020 Category: Research Source Type: clinical trials
Continuation of Protease-Inhibitor Based Second-Line Therapy vs. Switch to B/F/TAF in Virologically Suppressed Adults
Conditions: HIV-1-infection; Antiretroviral Therapy Interventions: Drug: Continuation of boosted PI; Drug: B/F/TAF Sponsors: Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic; Brigham and Women's Hospital; Harvard Medical School; Analysis Group, Inc.; Weill Medical College of Cornell University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 17, 2020 Category: Research Source Type: clinical trials
Early Fast-Track Versus Standard Care for Persons With HIV Initiating TLD
Condition: HIV-1-infection Interventions: Other: Early fast-track care; Other: Standard (deferred fast-track) care Sponsors: Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic; Brigham and Women's Hospital; Weill Medical College of Cornell University; Florida International University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 17, 2020 Category: Research Source Type: clinical trials
Continuation of Protease-Inhibitor Based Second-Line Therapy vs. Switch to B/F/TAF in Virologically Suppressed Adults
Conditions: HIV-1-infection; Antiretroviral Therapy Interventions: Drug: Continuation of boosted PI; Drug: B/F/TAF Sponsors: Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic; Brigham and Women's Hospital; Harvard Medical School; Analysis Group, Inc.; Weill Medical College of Cornell University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 17, 2020 Category: Research Source Type: clinical trials
Early Fast-Track Versus Standard Care for Persons With HIV Initiating TLD
Condition: HIV-1-infection Interventions: Other: Early fast-track care; Other: Standard (deferred fast-track) care Sponsors: Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic; Brigham and Women's Hospital; Weill Medical College of Cornell University; Florida International University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 17, 2020 Category: Research Source Type: clinical trials
Continuation of Protease-Inhibitor Based Second-Line Therapy vs. Switch to B/F/TAF in Virologically Suppressed Adults
Conditions: HIV-1-infection; Antiretroviral Therapy Interventions: Drug: Continuation of boosted PI; Drug: B/F/TAF Sponsors: Haitian Group for the Study of Kaposi's Sarcoma and Opportunistic; Brigham and Women's Hospital; Harvard Medical School; Analysis Group, Inc.; Weill Medical College of Cornell University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 17, 2020 Category: Research Source Type: clinical trials
